Vinpocetine, Ethyl apovincaminate, RGH-4405/improves cerebral blood flow/metabolism, anti-platelet

Description

This product is Vinpocetine (also known as Ethyl Apovincaminate) with CAS No. 42971-09-5. It is a pharmaceutical ingredient prepared by semi-synthetic technology using vincamine, a natural alkaloid extracted from Catharanthus minor of the Apocynaceae family, as the raw material. The molecular formula of the product is C₂₂H₂₆N₂O₂, and its molecular weight is approximately 350.46. It normally appears as white to off-white crystalline powder with a purity of over 98% (tested by HPLC). The pharmaceutical grade product complies with relevant pharmacopoeia standards. As a mature commercial pharmaceutical raw material, this product can be supplied in different grades such as pharmaceutical grade, food grade and reagent grade according to application purposes. It is mainly provided to pharmaceutical enterprises, health food manufacturers and scientific research institutions, and is one of the varieties with large circulation volume in domestic and overseas markets. The product shall be stored in a sealed, light-proof, cool and dry place.

Key Effects

Vinpocetine’s core function is associated with "improving cerebral blood circulation". Normal brain function relies on an adequate supply of blood and oxygen. Insufficient cerebral blood flow may lead to discomforts such as dizziness and memory decline. Vinpocetine helps dilate cerebral blood vessels, increases cerebral blood flow, improves the utilization of oxygen and glucose by brain cells, and exerts a certain protective effect on nerve cells. Therefore, it is widely used clinically for the treatment of cerebrovascular diseases and their sequelae. It is also adopted as an active ingredient in cognitive health products, serving as a representative cerebrovascular medicinal ingredient with both clinical value and health application potential.

Its specific functions can be summarized as follows:
Improve cerebral blood circulation: Help dilate cerebral blood vessels, increase cerebral blood flow and improve cerebral blood supply;
Neuroprotective effect: Help enhance the tolerance of brain cells to adverse conditions such as hypoxia;
Improve cognitive function: Applied in research and treatment of conditions related to memory loss and cognitive impairment;
Relieve vertigo and tinnitus: Used for adjuvant treatment of vertigo, tinnitus and other symptoms caused by cerebrovascular insufficiency;
Regulate cellular metabolism: Help brain cells utilize oxygen and glucose more efficiently;
Role as a research tool: As a representative compound of PDE inhibitors, it is used in relevant pharmacological studies.

Applications

This product is classified as a pharmaceutical API. It is mainly used for the production of pharmaceutical preparations for the treatment of cerebrovascular diseases, and also has stable applications in cognitive health dietary supplements and scientific research.

Its main application areas are summarized as follows:
Medicines for cerebrovascular diseases: Active pharmaceutical ingredient for drugs treating cerebral ischemia, cerebral arteriosclerosis, sequelae of stroke and other conditions;
Treatment of cognitive impairment: Raw material for preparations related to memory loss and cognitive decline;
Symptom-relieving medicines: Raw material for drugs that relieve symptoms such as vertigo and tinnitus;
Health food sector: Functional raw material for dietary supplements supporting cognitive health and mental capacity;
Scientific research: Tool compound used in studies on PDE inhibition and neuroprotective mechanisms;
Export trade and raw material supply: Supplied as a pharmaceutical raw material to pharmaceutical manufacturers, health food producers, research institutions and traders, with specifications customizable according to customer requirements.